Navigation Links
Eyeforpharma's Marketing Summit is shaping up to be the biggest event of its kind ever
Date:9/9/2008

Pharma’s Successful changing marketing approaches

LONDON, September 8, 2008 / b3c newswire /  – The looming recession certainly does not seem to have hit the European pharmaceutical industry yet.  With more than twice as many registered attendees as in past years, eyeforpharma’s upcoming Marketing Summit Europe, October 20-21 in Zurich is shaping up to be the biggest event of its kind ever.

Companies obviously know that thriving in today’s market means staying on top of their game and perhaps nowhere is that more important than in the rapidly changing pharmaceutical space.

Ultimately, the most successful pharmaceutical companies,  says Michael Zaiac, assistant vice president medical affairs EMEA at Wyeth, will be those who invest heavily in understanding the industry’s new stakeholders – especially patients, payers and policy makers – and employ an early feedback loop into their clinical discovery and development programs to steer products toward better meeting the needs of these stakeholders.

Companies that are quick on the uptake and willing to invest in the necessary skill sets to connect with these new customers, by either acquiring them from outside or training existing employees, Zaiac says, can positively differentiate themselves from their competitors and bring products to market more successfully.

Baba Awopetu, Manager of Brand Strategy EMEA at Stryker, says more stakeholders mean a more complex and complicated environment, and pharma marketers must consider where the power base lies and how much influence each group has given a company’s specific circumstances. Companies may find they have primary and secondary stakeholders, depending on the therapy area, product lifecycle or other factors, he suggests.

With a wider audience, pharmas will need to focus, prioritize and better target their messages, Awopetu says. “We have to cover a lot more with less, so our messages must be better targeted and our marketing efficiency is being forced to improve,” he says.

To learn more about marketing to pharma’s changing customer base, join Zaiac and Awopetu, who will be speaking and chairing sessions at eyeforpharma’s Marketing Summit Europe, October 20-21 in Zurich. For additional details or to register, visit www.eyeforpharma.com/marketing08/


'/>"/>
b3c newswire

Related biology technology :

1. European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreichs Ataxia by Santhera
2. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
3. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
4. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
5. Phlo Affiliate Hires Chief Marketing Officer With Extensive Global Experience
6. Communicating Clinical Trial Data: Timing Remains Key Challenge for Marketing Teams
7. Bioenergy Life Science and Integrative Therapeutics, Inc. Form Exclusive Co-Marketing Alliance
8. Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug
9. Phlo Affiliate Names Director Of Marketing
10. Southern Research Expands Sales and Marketing Agreement with Absorption Systems to Service European Market
11. Natural Nutrition Launches International Marketing Campaign for New All Natural Analgesic: BLUE LIGHTNING(TM) Fast Pain Relief
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 27, 2016 , ... Cancer experts from Austria, Hungary, Switzerland, ... a new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just ... now. , Biomarkers are components in the blood, tissue or body fluids ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
Breaking Biology Technology:
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/22/2016)... India , March 22, 2016 /PRNewswire/ ... market research report "Electronic Sensors Market for Consumer ... Proximity, & Others), Application (Communication & IT, ... Geography - Global Forecast to 2022", published ... industry is expected to reach USD 26.76 ...
Breaking Biology News(10 mins):